Millennium wins injunction against Juno over generic cancer drug
US-based Millennium Pharmaceuticals has secured a temporary injunction that bans generic drug maker Juno Pharmaceuticals from importing or selling its cheap version of breakthrough cancer drug Velcade in Australia.
For information on rights and reprints, contact [email protected]
